MetLife(MET) - 2025 Q4 - Earnings Call Transcript

Financial Data and Key Metrics Changes - In Q4 2025, MetLife reported adjusted earnings of $1.6 billion or $2.49 per share, with adjusted EPS excluding notable items at $2.58, a 24% increase from $2.08 a year ago, marking the highest single EPS quarter for the company [10][19] - For the full year 2025, adjusted earnings excluding notable items reached $6 billion or $8.89 per share, up roughly 10% [11][19] - The company achieved 10% adjusted EPS growth and an adjusted return on equity (ROE) of 16%, within the target range of 15%-17% [8][19] Business Line Data and Key Metrics Changes - Group Benefits adjusted earnings for Q4 were $465 million, contributing to full-year adjusted earnings of $1.7 billion, with life mortality trends improving [12][22] - Retirement and Income Solutions (RIS) adjusted earnings were $454 million for Q4, up 18%, with full-year earnings also at $1.7 billion, benefiting from record origination in pension risk transfers [13][24] - Asia adjusted earnings were $444 million for Q4, essentially flat year-over-year, while Latin America adjusted earnings rose 13% to $227 million [25][26] Market Data and Key Metrics Changes - Asia saw constant currency sales jump 18% in 2025, with Japan contributing significantly, while Latin America sales rose by 12%, led by Mexico [5][26] - EMEA adjusted earnings increased 64%, driven by robust volume growth and favorable underwriting margins [26] Company Strategy and Development Direction - MetLife's "New Frontier" strategy emphasizes growth, capital deployment, and operational discipline, with a focus on enhancing market leadership in group benefits and asset management [4][17] - The acquisition of PineBridge Investments established a new business segment, MetLife Investment Management, which had $742 billion in assets under management by year-end [5][27] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving five-year commitments for adjusted EPS, adjusted ROE, and free cash flow, despite evolving macroeconomic conditions [9][34] - The company anticipates continued growth in 2026, with adjusted EPS growth expected to remain in double digits and adjusted ROE targeted at 15%-17% [34] Other Important Information - MetLife returned approximately $4.4 billion to shareholders in 2025 through stock repurchases and dividends, while also funding acquisitions and investments totaling about $1.2 billion [6][15] - The company paid roughly $50 billion in policyholder benefits and claims in 2025, highlighting its commitment to customer service [18] Q&A Session Summary Question: Comments on Group Benefits renewal season and pricing - Management noted robust results in persistency, particularly in dental, with good sales growth across the business, including strength in disability [46] Question: Impact of macroeconomic volatility in Japan - Management acknowledged short-term impacts on sales due to macroeconomic fluctuations but emphasized a solid value proposition and strong sales results [48][49] Question: Changes in GAAP earnings for real estate accounting - Management explained the change aimed to better reflect cash flows and returns, aligning with overall economics of the asset class [52][54] Question: Outlook for U.S. retail retirement space - Management highlighted successful execution of flow reinsurance deals, enhancing liability origination and capital flexibility [61][64] Question: Trends in surrender activity in Japan - Management reported a slight increase in surrenders in Q4 but expected them to return to long-term assumptions in 2026 [65] Question: Group disability experience and outlook - Management indicated pressure in disability results but did not expect this to indicate a trend into 2026, citing strong full-year performance [78]